Team GP2 provides CRN researchers with a direct connection to the Global Parkinson’s Genetics Program (GP2), an international collaborative effort aimed at making transformational progress in Parkinson’s disease (PD) genetics.
The existing infrastructure of GP2 can be leveraged by CRN Teams, for example to centralize and standardize genotyping and whole genome sequencing (WGS) of Parkinson’s disease tissues and cell lines. Moreover, teams can utilize GP2 expertise to identify novel genetic links for targets of interest to PD.